BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 26864644)

  • 1. LASIK surgery of granular corneal dystrophy type 2 patients leads to accumulation and differential proteolytic processing of transforming growth factor beta-induced protein (TGFBIp).
    Poulsen ET; Nielsen NS; Jensen MM; Nielsen E; Hjortdal J; Kim EK; Enghild JJ
    Proteomics; 2016 Feb; 16(3):539-43. PubMed ID: 26864644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone methylation levels correlate with TGFBIp and extracellular matrix gene expression in normal and granular corneal dystrophy type 2 corneal fibroblasts.
    Maeng YS; Lee GH; Choi SI; Kim KS; Kim EK
    BMC Med Genomics; 2015 Nov; 8():74. PubMed ID: 26553048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGF-β regulates TGFBIp expression in corneal fibroblasts via miR-21, miR-181a, and Smad signaling.
    Choi SI; Jin JY; Maeng YS; Kim TI; Kim EK
    Biochem Biophys Res Commun; 2016 Mar; 472(1):150-5. PubMed ID: 26915797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autophagy in granular corneal dystrophy type 2.
    Choi SI; Kim EK
    Exp Eye Res; 2016 Mar; 144():14-21. PubMed ID: 26386150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A clinical and histopathologic examination of accelerated TGFBIp deposition after LASIK in combined granular-lattice corneal dystrophy.
    Aldave AJ; Sonmez B; Forstot SL; Rayner SA; Yellore VS; Glasgow BJ
    Am J Ophthalmol; 2007 Mar; 143(3):416-9. PubMed ID: 17317389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 4-Phenylbutyric acid reduces mutant-TGFBIp levels and ER stress through activation of ERAD pathway in corneal fibroblasts of granular corneal dystrophy type 2.
    Choi SI; Lee E; Jeong JB; Akuzum B; Maeng YS; Kim TI; Kim EK
    Biochem Biophys Res Commun; 2016 Sep; 477(4):841-846. PubMed ID: 27373828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of two phenotypically distinct lattice corneal dystrophies caused by mutations in the transforming growth factor beta induced (TGFBI) gene.
    Poulsen ET; Runager K; Risør MW; Dyrlund TF; Scavenius C; Karring H; Praetorius J; Vorum H; Otzen DE; Klintworth GK; Enghild JJ
    Proteomics Clin Appl; 2014 Apr; 8(3-4):168-77. PubMed ID: 24302499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein Analysis of the TGFBI
    Lukassen MV; Poulsen ET; Donaghy J; Mogensen EH; Christie KA; Roshanravan H; DeDioniso L; Nesbit MA; Moore T; Enghild JJ
    Proteomics Clin Appl; 2020 Nov; 14(6):e1900072. PubMed ID: 32558206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor beta induced protein accumulation in granular corneal dystrophy type III (Reis-Bücklers dystrophy). Identification by mass spectrometry in 15 year old two-dimensional protein gels.
    Hedegaard CJ; Thøgersen IB; Enghild JJ; Klintworth GK; Møller-Pedersen T
    Mol Vis; 2003 Aug; 9():355-9. PubMed ID: 12942051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serine protease HtrA1 accumulates in corneal transforming growth factor beta induced protein (TGFBIp) amyloid deposits.
    Karring H; Poulsen ET; Runager K; Thøgersen IB; Klintworth GK; Højrup P; Enghild JJ
    Mol Vis; 2013; 19():861-76. PubMed ID: 23592924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysophosphatidic acid activates TGFBIp expression in human corneal fibroblasts through a TGF-β1-dependent pathway.
    Jeon ES; Kim JH; Ryu H; Kim EK
    Cell Signal; 2012 Jun; 24(6):1241-50. PubMed ID: 22374302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysosomal dysfunction of corneal fibroblasts underlies the pathogenesis of Granular Corneal Dystrophy Type 2 and can be rescued by TFEB.
    Choi SI; Woo JH; Kim EK
    J Cell Mol Med; 2020 Sep; 24(18):10343-10355. PubMed ID: 32667742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and Functional Implications of Human Transforming Growth Factor β-Induced Protein, TGFBIp, in Corneal Dystrophies.
    García-Castellanos R; Nielsen NS; Runager K; Thøgersen IB; Lukassen MV; Poulsen ET; Goulas T; Enghild JJ; Gomis-Rüth FX
    Structure; 2017 Nov; 25(11):1740-1750.e2. PubMed ID: 28988748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation-induced dimerization of transforming growth factor-β-induced protein may drive protein aggregation in granular corneal dystrophy.
    Nielsen NS; Gadeberg TAF; Poulsen ET; Harwood SL; Weberskov CE; Pedersen JS; Andersen GR; Enghild JJ
    J Biol Chem; 2021 Jul; 297(1):100858. PubMed ID: 34097874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of position-specific single-point mutations and biophysical characterization of amyloidogenic peptide fragments identified from lattice corneal dystrophy patients.
    Anandalakshmi V; Murugan E; Leng EGT; Ting LW; Chaurasia SS; Yamazaki T; Nagashima T; George BL; Peh GSL; Pervushin K; Lakshminarayanan R; Mehta JS
    Biochem J; 2017 May; 474(10):1705-1725. PubMed ID: 28381645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extremely varied phenotypes in granular corneal dystrophy type 2 heterozygotes.
    Han KE; Choi SI; Chung WS; Jung SH; Katsanis N; Kim TI; Kim EK
    Mol Vis; 2012; 18():1755-62. PubMed ID: 22815629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autophagy is induced by raptor degradation via the ubiquitin/proteasome system in granular corneal dystrophy type 2.
    Choi SI; Maeng YS; Kim KS; Kim TI; Kim EK
    Biochem Biophys Res Commun; 2014 Aug; 450(4):1505-11. PubMed ID: 25044116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation in transforming growth factor beta induced protein associated with granular corneal dystrophy type 1 reduces the proteolytic susceptibility through local structural stabilization.
    Underhaug J; Koldsø H; Runager K; Nielsen JT; Sørensen CS; Kristensen T; Otzen DE; Karring H; Malmendal A; Schiøtt B; Enghild JJ; Nielsen NC
    Biochim Biophys Acta; 2013 Dec; 1834(12):2812-22. PubMed ID: 24129074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical mechanisms of aggregation in TGFBI-linked corneal dystrophies.
    Nielsen NS; Poulsen ET; Lukassen MV; Chao Shern C; Mogensen EH; Weberskov CE; DeDionisio L; Schauser L; Moore TCB; Otzen DE; Hjortdal J; Enghild JJ
    Prog Retin Eye Res; 2020 Jul; 77():100843. PubMed ID: 32004730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical findings and treatments of granular corneal dystrophy type 2 (avellino corneal dystrophy): a review of the literature.
    Han KE; Kim TI; Chung WS; Choi SI; Kim BY; Kim EK
    Eye Contact Lens; 2010 Sep; 36(5):296-9. PubMed ID: 20724852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.